Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Strategy $2.1 billion perpetual strife preferred stock at-the-market offering
The perpetual strife preferred stock is listed on the Nasdaq Global Select Market
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2030, 2032 and 2035
Equinix €1.5 billion green bond offering
We advised Equinix on the investment-grade notes offering
Uber Technologies $1.15 billion exchangeable notes offering
The 0% exchangeable senior notes are due 2028
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Shift4 Payments $550 million and €680 million notes offerings
The high-yield notes are part of the financing for Shift4 Payments’ acquisition of Global Blue Group Holdings
Akamai Technologies $1.725 billion convertible senior notes offering
The convertible senior notes are due 2033
Galaxy corporate reorganization and Nasdaq listing
We are advising Galaxy on its Delaware domestication and Nasdaq listing
Caterpillar $2 billion notes offering
The investment-grade notes are due 2035 and 2055
LYB International Finance III $500 million guaranteed bond offering
The guaranteed notes are due 2035